ArticleGynecologic oncology reports2022

Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.

Erica V Carballo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.